Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Hits New 1-Year High – Still a Buy?

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) reached a new 52-week high on Thursday . The company traded as high as $11.63 and last traded at $11.63, with a volume of 3836 shares. The stock had previously closed at $11.51.

Shionogi & Co., Ltd. Unsponsored ADR Price Performance

The company has a market cap of $19.99 billion, a price-to-earnings ratio of 15.46, a P/E/G ratio of 1.14 and a beta of 0.19. The company’s 50-day simple moving average is $9.80 and its 200-day simple moving average is $9.01. The company has a debt-to-equity ratio of 0.01, a current ratio of 5.84 and a quick ratio of 5.21.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last announced its earnings results on Friday, January 30th. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.19 by $0.09. The business had revenue of $966.53 million during the quarter, compared to the consensus estimate of $848.42 million. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 41.82% and a return on equity of 13.70%. On average, equities research analysts anticipate that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 EPS for the current year.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.